(PDF) Vienna, Austria – The Open PHACTS consortium is proud to have been awarded first prize in the Linked Open Data Award category of the European Linked Data Contest (ELDC).
The ELDC has been established to recognise Europe’s crème de la crème of linked data and semantic web achievements. Prizes are awarded to stories, products, projects or persons presenting novel and innovative projects, products and industry implementations involving linked data. The ELDC also aims to build a directory of the best European projects in the domains of linked data and the semantic web.
An international jury of ambassadors from over 15 European countries elected Open PHACTS as the winner, judging that the Open PHACTS project excelled in all aspects of the contest’s assessment criteria:
- shows a high degree of innovation
- triggers network effects
- embraces open standards
- proves technological matureness
- shows great potential to be utilised in multiple domains
- achieves a high degree of comprehensibility for users and the public
Open PHACTS is honoured to be chosen as the first winner of the ELDC’s Linked Open Data Award, and to be included in the ELDC directory of European linked data and semantic web projects.
“It is fantastic to see the successes of the Open PHACTS project recognised by the ELDC in this award. Over the course of this project we have been proud to deliver an unprecedented data integration infrastructure to support drug discovery research, thanks to the unparalleled range of expertise of our consortium members. We look forward to continuing to build on these achievements through the successor organisation to this project, the Open PHACTS Foundation.”
Professor Gerhard Ecker, University of Vienna
The Open PHACTS Project
The Open PHACTS project is a knowledge management project of the Innovative Medicines Initiative, which began in March 2011. The project has received support from the IMI Joint Undertaking under grant agreement n° 115191, and has developed the Open PHACTS Discovery Platform to answer key scientific questions for applied life sciences research and development. This platform connects open data from 12 different sources including chemical compounds, protein targets, biological pathways and tissues, and diseases.
The 30-member consortium includes academic and pharmaceutical industrial partners, and has developed an additional community of application developers and smaller enterprises to use the Open PHACTS Discovery Platform to meet the needs of drug discovery scientists. The data integrated by Open PHACTS currently contains over three billion triples, and the diversity and size of data sets are growing rapidly.
The Open PHACTS Foundation
The Open PHACTS Foundation is a not-for-profit membership organisation, established to ensure the sustainability of the Open PHACTS Discovery Platform and other outcomes of the Open PHACTS project. The Open PHACTS Foundation is a registered charity in the United Kingdom.
The Innovative Medicines Initiative (IMI)
The Innovative Medicines Initiative is Europe’s largest public-private initiative. Resources are composed of a financial contribution from the EU Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in-kind contribution.